- $20.24bn
- $20.67bn
- $4.50bn
- 79
- 18
- 59
- 51
2019 December 29th | 2021 January 3rd | 2022 January 2nd | 2023 December 31st | 2023 January 1st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,543 | 3,239 | 4,526 | 4,504 | 4,584 |
Cost of Revenue | |||||
Gross Profit | 2,467 | 2,203 | 3,154 | 2,744 | 2,972 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,504 | 2,659 | 4,649 | 5,573 | 8,763 |
Operating Profit | 1,039 | 580 | -123 | -1,069 | -4,179 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,118 | 856 | 884 | -1,117 | -4,336 |
Provision for Income Taxes | |||||
Net Income After Taxes | 990 | 656 | 762 | -1,161 | -4,404 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,002 | 656 | 762 | -1,161 | -4,404 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,002 | 656 | 762 | -1,161 | -4,404 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.4 | 4.43 | 5.05 | -3.24 | -9.28 |